Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group

by Eleonora Gaetani, Fabiana Agostini, Angelo Porfidia, Igor Giarretta, Daniela Feliciani, Luigi Di Martino, Annalisa Tortora, Antonio Gasbarrini, Roberto Pola, on behalf of the Multidisciplinary Gemelli Group for HHT
Published 2019-12-01

Beneficial Effects of Remote Medical Care for Patients with Hereditary Hemorrhagic Telangiectasia during the COVID-19 Pandemic

by Eleonora Gaetani, Fabiana Agostini, Luigi Di Martino, Denis Occhipinti, Giulio Cesare Passali, Mariaconsiglia Santantonio, Giuseppe Marano, Marianna Mazza, Roberto Pola, on behalf of the Multidisciplinary Gemelli Group for HHT
Published 2021-05-01